Clarisse Dromain

Centre Hospitalier Universitaire Vaudois

ORCID: 0000-0002-2999-1958

Also affiliated with University of Lausanne

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Novel Tumor Growth Rate Analysis in the Randomized CLARINET Study Establishes the Efficacy of Lanreotide Depot/Autogel 120 mg with Prolonged Administration in Indolent Neuroendocrine Tumors”.

Novel Tumor Growth Rate Analysis in the Randomized CLARINET Study Establishes the Efficacy of Lanreotide Depot/Autogel 120 mg with Prolonged Administration in Indolent Neuroendocrine Tumors

The Oncologist(2021)10.1002/onco.13669

N/A

0DataRank · unranked

17 citations

Arturo Loaiza‐Bonilla, Beloo Mirakhur, Thomas J.R. Beveridge, Antonio Tito Fojo, Clarisse Dromain

Proposal of early CT morphological criteria for response of liver metastases to systemic treatments in gastroenteropancreatic neuroendocrine tumors: Alternatives to RECIST

Journal of Neuroendocrinology(2023)10.1111/jne.13311

N/A

0DataRank · unranked

5 citations

Matthieu Resche‐Rigon, Clarisse Dromain, Angela Lamarca, Anna La Salvia, Lesley Baker +27 more